TP53 and acute myeloid leukemia: Only one, ETV6, exhibited high expression in CBF and NK AMLs and a significant difference in expression in TP53-mutated AML with 12p loss (adjusted p-value=1.0×10−4, Figure 5C, Supplementary Table 8).